These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16978034)

  • 21. Imaging Investigation of Thyroid Eye Disease.
    Siakallis LC; Uddin JM; Miszkiel KA
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S41-S51. PubMed ID: 29905640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of patients with thyroid eye disease.
    Karra E; Yousseif A; Rose GE; Baldeweg SE
    Br J Hosp Med (Lond); 2016 Jan; 77(1):C6-9. PubMed ID: 26903468
    [No Abstract]   [Full Text] [Related]  

  • 23. Thyroid eye disease with choroidal folds.
    Tran AQ; Zhang-Nunes SX; Cahill K; Alabiad CR; Shriver EM; Ho T; Weinberg DA; Couch SM; Schlachter DM; Nguyen J; Wester ST
    Orbit; 2021 Jun; 40(3):206-214. PubMed ID: 32326785
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of thyroid ophthalmopathy--a clinical case].
    Andrei S; Zemba M; Zugravu V; Enache V; Renetti A; Spiroiu C
    Oftalmologia; 2007; 51(1):49-55. PubMed ID: 17605272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology.
    Sobel RK; Aakalu VK; Vagefi MR; Foster JA; Tao JP; Freitag SK; Wladis EJ; McCulley TJ; Yen MT
    Ophthalmology; 2022 Apr; 129(4):450-455. PubMed ID: 34895729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Pediatric Thyroid Eye Disease: Surgical Case Series.
    Wu CY; Elner VM; Kahana A
    Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S186-S188. PubMed ID: 26524159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid eye disease: current and potential medical management.
    Pouso-Diz JM; Abalo-Lojo JM; Gonzalez F
    Int Ophthalmol; 2020 Apr; 40(4):1035-1048. PubMed ID: 31919775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.
    Strianese D; Rossi F
    Eye (Lond); 2019 Feb; 33(2):191-199. PubMed ID: 30610229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid eye disease: therapy in the active phase.
    Bhatti MT; Dutton JJ
    J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary diagnostic and therapeutic abilities in childhood thyroid-associated ophthalmopathy with a clinical case description.
    Kaleva NN; Pehlivanova NI; Misheva ZP; Shabanova TD; Balabanova AV
    Folia Med (Plovdiv); 2010; 52(2):57-63. PubMed ID: 20836398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review.
    Li X; Li S; Fan W; Rokohl AC; Ju S; Ju X; Guo Y; Heindl LM
    Int Ophthalmol; 2023 Apr; 43(4):1437-1449. PubMed ID: 36272013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of active corticosteroid-resistant graves' orbitopathy.
    Pérez-Moreiras JV; Alvarez-López A; Gómez EC
    Ophthalmic Plast Reconstr Surg; 2014; 30(2):162-7. PubMed ID: 24503568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Era in the Treatment of Thyroid Eye Disease.
    Patel A; Yang H; Douglas RS
    Am J Ophthalmol; 2019 Dec; 208():281-288. PubMed ID: 31377284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid eye disease.
    Hsu HJ; Hsu CK; Chen TS; Hsu CH
    QJM; 2016 Jan; 109(1):67-8. PubMed ID: 26450988
    [No Abstract]   [Full Text] [Related]  

  • 36. A mild Grave's ophthalmopathy during pregnancy.
    Abbouda A; Trimboli P; Bruscolini A
    Semin Ophthalmol; 2014 Jan; 29(1):8-10. PubMed ID: 24171793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy.
    Ujhelyi B; Erdei A; Galuska L; Varga J; Szabados L; Balazs E; Bodor M; Cseke B; Karanyi Z; Leovey A; Mezosi E; Burman KD; Berta A; Nagy EV
    Thyroid; 2009 Apr; 19(4):375-80. PubMed ID: 19355827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric Thyroid Eye Disease: Clinical Characteristics and Orbital Decompression Outcomes.
    Chua MR; Tomlinson LA; Binenbaum G; Katowitz WR
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S52-S55. PubMed ID: 29985836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.